PureTech Health (LON:PRTC) Shares Cross Above Fifty Day Moving Average - What's Next?

Key Points

• PureTech Health shares rose above their fifty-day moving average of GBX 135.12 during trading, reaching a high of GBX 146.40 before closing at GBX 138.
• The company's insider activity included the purchase of 167,739 shares by Bharatt Chowrira at a significantly lower price of £1 ($0.01) per share, which indicates strong insider confidence.
• PureTech Health has a strong liquidity position with a current ratio of 3.68 and a market capitalization of £414.53 million, although it is currently trading at a negative price-to-earnings ratio of -5.66.

PureTech Health plc (LON:PRTC - Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 135.12 ($1.80) and traded as high as GBX 146.40 ($1.95). PureTech Health shares last traded at GBX 138 ($1.83), with a volume of 233,641 shares.

PureTech Health Trading Down 1.0%

The company has a market cap of £401.31 million, a price-to-earnings ratio of -5.48 and a beta of 1.02. The company's 50 day moving average price is GBX 135.14 and its 200 day moving average price is GBX 134.22. The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68.

Insider Activity

In related news, insider Bharatt Chowrira purchased 167,739 shares of the firm's stock in a transaction on Thursday, July 3rd. The shares were bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,677.39 ($2,230.28). Corporate insiders own 15.93% of the company's stock.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.